Adverse Event reporting information can be found at the bottom of the page
Optimal Management of ADHD
Image
Goal Based Treatment Strategies for ADHD in Adults
Dr. Kenny Handelman, a psychiatrist specialising in child, adolescent, and adult mental health, as well as an assistant clinical professor at a Canadian university, explores goal-oriented treatment approaches for adults diagnosed with ADHD.
Image
The impact of meta-analysis assessing the efficacy and tolerability of ADHD medications
Prof. Raja Mukherjee provides expert insight into the Cortese et al. meta-analysis, evaluating ADHD treatment efficacy and tolerability, and discussing clinical implications for personalised care and medication strategies.
Image
Optimising treatment for Adults with ADHD
Dr. Joe Johnson speaks on optimising the treatment of adults with ADHD.
Image
ADHD Treatment optimisation in clinical practice for children and young people
Dr. Matt McConkey delves into the optimisation of ADHD treatment in clinical practice.
Image
A place for amphetamines in clinical practice
Dr. Helen Tindle reviews the place of amphetamines in the treatment pathway, aligned to the ADHD NICE guidelines 2018.
Image
The role of Intuniv ▼ (guanfacine) in clinical practice
Dr. Jeremy de Bono looks at the role of Intuniv ▼ (guanfacine) in clinical practice.
Image
Cortese et al. 2018: A meta-analysis of the safety and efficacy of medicines for ADHD
This animated video explores the results of the Cortese et al. 2018 study and provides an overview of the use, efficacy and safety data for Elvanse (lisdexamfetamine dimesylate) and the NICE recommendation.
C-APROM/GB/NS/1241 | September 2025
You're leaving us
You will be redirected to an external website that is neither owned, or controlled by Takeda UK Ltd.
Takeda UK Ltd does not review, endorse or control the content of any non-Takeda owned site.
Takeda UK Ltd is not responsible for the accuracy, content, practices or standards of any non-Takeda resources accessed through a link on this site.
